BALTIMORE, MD — US researchers have devised and validated a novel method of estimating LDL-cholesterol levels [1]. The new method, which was tested and validated in more than 1.3 million individuals, ...
Juxtapid has been available to treat adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes extremely high levels of LDL cholesterol.